PharmiWeb

Molecular Infectious Disease Testing Market: Growth, Innovations, and Opportunities

Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...
ascopubs.org

EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing

Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities A total of 7,413 tumor specimens were tested. The ...
The American Journal of Managed Care

Recognizing and Testing for ROS1 in NSCLC

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...
ascopubs.org

Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma We conducted a real-world cohort study ...
Business Insider

GRIP Molecular Technologies and Molecular Testing Labs Announce Collaborative Development of Groundbreaking At-Home Disease Testing Platform

ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ -- Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing ...
The American Journal of Managed Care

Combined Diagnostic Approach Improves Accuracy in Differentiating Eczema From Psoriasis

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...

Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider

Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider. U.S. Molecular Diagnostics ...